Avaforce 100 mg (avanafil) use in liver disease should be advised and monitored by a qualified doctor, typically a general physician, urologist, or hepatologist, depending on how advanced the liver condition is. Because avanafil is mainly broken down by the liver, any liver disease can change how the body handles the drug, increasing the risk of side effects.
Doctors usually decide based on the severity of liver impairment (mild, moderate, or severe, often classified by Child‑Pugh score). In mild liver disease, a lower starting dose for example, 50 mg instead of Avaforce 100 mg may be acceptable with close watch, while in moderate disease the dose may be reduced further or the interval between doses extended. In severe liver disease, Avaforce 100 mg is often avoided altogether or only used if the benefit clearly outweighs the risk, and then under strict specialist supervision.
A hepatologist or liver‑specialist doctor may be involved if there is cirrhosis, elevated liver enzymes, or other signs of serious liver damage. Because there is limited data on Avaforce 100 in severe liver disease, any decision to use it must be individualized and guided by a treating physician who can order liver‑function tests, review other medicines, and adjust the dose or switch to a safer ED treatment if needed.